theMednetRegister

Hematology

Dermatomyositis   

Questions discussed in this category

What is your approach to screening for malignancy in dermatomyositis patients who do not have a high risk antibody profile and whose disease responds well to treatment?
Do you pursue screening beyond age-appropriate malignancy screening, especially in younger patients? For how long do you continue to monitor beyond th...
1 Answer available


Papers discussed in this category

Nature reviews. Rheumatology, 2023 Nov 09
International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.

Related Topics in Hematology

Copyright © 2025 theMednet
All Rights Reserved.